Related Experiment Video

Updated: Apr 29, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

90.5K

Infant toxicology: state of the science and considerations in evaluation of safety

April Neal-Kluever1, Jason Aungst1, Yan Gu1

  • 1United States Food and Drug Administration, Center For Food Safety and Applied Nutrition, Office of Food Additive Safety, Division of Food Contact Notifications, United States.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|May 15, 2014
PubMed

Insights

Infant formula packaging safety requires special evaluation due to infants' unique physiology and higher consumption relative to body weight. This review addresses biological factors, testing protocols, and data gaps for infant exposure safety.

Area of Science:

  • Toxicology
  • Pediatrics
  • Food Safety

Background:

  • Infants (0-6 months) have distinct physiology and higher food intake relative to body weight compared to adults.
  • Infant formula is often the sole food source during a critical developmental period.
  • Unique infant susceptibilities necessitate tailored safety evaluations for food contact materials.

Purpose of the Study:

  • To review biological and exposure factors influencing infant safety assessments for food contact products.
  • To summarize existing reproductive and developmental toxicity testing protocols.
  • To identify data gaps in the safety evaluation of infant-exposed products.

Main Methods:

  • Literature review of infant physiology and toxicology.
  • Analysis of current reproductive and developmental toxicity testing guidelines.
  • Identification of knowledge gaps in infant-specific safety assessments.

Main Results:

  • Infant physiology and exposure patterns differ significantly from adults, impacting risk assessment.
  • Current toxicity testing protocols may not fully address infant-specific vulnerabilities.
  • Several data gaps exist regarding the long-term effects of early-life exposures from packaging.

Conclusions:

  • Specialized safety evaluations are crucial for infant formula packaging.
  • Existing testing frameworks need refinement to account for infant developmental stages.
  • Further research is needed to address identified data gaps for comprehensive infant safety.

Keywords:
Developmental toxicologyInfantsSafety assessmentToxicology

More Related Videos

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach

Published on: June 11, 2017

11.8K
Assessment of Chemical Toxicity in Adult Drosophila Melanogaster07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

4.9K

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
204
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
314
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
295
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
409
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
229